Skip to main content
. 2003 Apr 1;88(7):1032–1034. doi: 10.1038/sj.bjc.6600844

Table 2. Frequency of HER2-positivity in primary breast carcinomas according to parity, ages at menarche and menopause of the patients.

Groups No. of cases No. of HER2+ cases Observed % HER2+ OR Mean from literature Expected % HER2+ considering no protection for HER2+ tumours
Parity          
 0–1 805 168 20.9 1 20.9
 2–3 709 169 23.8* 0.95 22.0
 >3 141 43 30.5* 0.75 27.9
           
Menarche          
 <12 247 53 21.5 1 21.5
 12–13 806 184 22.8  
 >13 639 158 24.7 0.85 25.2
           
Menopause          
 <45 194 45 23.2 1 23.2
 45–49 298 68 22.8  
 >49 558 120 21.5 1.2 19.3
*P=0.03 by χ2. OR=Odds ratio.